Home>People>Doctoral Candidates

Mira Sleiman

Germany
Email: mira.sleiman@leibniz-fli.de

tba

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI): Kirstein Research Group

First Supervisor:

Janine Kirstein (Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))

Publications 2025:

  • Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau
    Hirsch F, Läubli N, Kelkar A, Sleiman M, Woitzat Y, Gallrein C, Gumz V, Kaur Kalsi G, Fernandez-Villegas A, Kaminski Schierle G, Kirstein J
    bioRxiv 2025, https://doi.org/10.1101/2025.07.

    • Publications 2024:

    • HSP110 is a modulator of amyloid beta (Aβ) aggregation and proteotoxicity.
      Montresor S, Pigazzini ML, Baskaran S, Sleiman M, Adhikari G, Basilicata L, Secker L, Jacob N, Ehlert Y, Kelkar A, Kalsi GK, Kulkarni N, Spellerberg P, Kirstein J
      J Neurochem 2024, 169(1), e16214